Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Haemocomplettan P in Congenital Fibrinogen Deficiency
NCT00496262Phase 2Completed
- Sponsor
- CSL Limited
- Start
- Jul 2007
- Primary completion
- May 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of Fibrinogen human in congenital fibrinogen deficiency (CFD), sponsored by CSL Limited. Started Jul 2007; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
congenital fibrinogen deficiency (CFD)
Beyond the preview
Go deeper on NCT00496262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00496262.